 |
Social Media & Marketing
Pharma's Prescription for Social Media Value
When it comes to marketing, particularly through social media channels, measurement of return on investment (ROI) poses its own set of challenges. Peter Friedman looks at five types of metrics, measurements, and insights that can help drive and prove the value of a company’s social media programs
...Read more |
 |
Comment
Express Scripts 2020: Back to the Future?
The clocks are ticking for Express Scripts. Having achieved formidable “size and scale,” how will the nation’s largest pharmacy benefit managersynchronize with value-based health care? With each day, between the medical and pharmacy benefits, the time to value is diverging. Stephen E. Littlejohn reports
...Read more |
While the regulatory environment has been evolving over the past few years and conducting business under the Sunshine law has been challenging, submissions published during the course of 2013 and 2014 highlighted some best practices life sciences companies can use to develop a tactical roadmap to address aggregate spend needs. Learn more about these best practices in a new IMS Health white paper.
 Download now |
Regulatory
“Sunshine” Goes Global
As the U.S. Open Payments system improves operations and resolves discrepancies, the emergence of widely diverse and contradictory transparency programs in Europe and other nations raises new challenges for pharma companies, writes Jill Wechsler
...Read more |
Redefining what marketing means to pharma. Creating engagements with value and purpose. Realize your potential with integrated services from Intouch Solutions. Intouchsol.com/Genome
 Learn More
 |
Regulatory
FDA's Hot August
August was sizzling on the East Coast, but perhaps it was most uncomfortable in the air-conditioned confines of FDA’s offices. The Agency’s boil came with an early peak high and showed little sign of letting up by mid month, writes Casey McDonald
...Read more |
Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What's Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
 Contact your sales rep for more information and to secure your sponsorship. |
Technology
Time for a Wearable Strategy
Analysts are saying that more than 4 million Apple Watches were sold in the Q2 2015, grabbing up to 75 percent of the smartwatch market, way ahead of nearest rival Samsung. This continued rise of wearable technology is thanks in particular to health and fitness applications. Peter Houston reports
...Read more |
Pharmaceutical Executive E-Book – Coming October 2015: Changing Contours of Commercialization: Impact of US Health Reform on Patients, Payers and Providers
Key Topics include:
- Phase-in of the 2010 Affordable Care Act: Five stages of pain and plenty
- Pay for Performance and Shared Savings Programs – Implications for Pharma Marketers
- How ACO models are driving physician and provider decision-making
- Primer on policies and financial drivers impacting payer markets – MLR, MSSP, CMS etc.
 Contact your sales rep for more information and to secure your sponsorship. |
 |
 //Coherus BioSciences (Redwood City, CA) appointed Juliana M. Reed as Vice President, Government Affairs.//EMD Serono, the U.S. biopharmaceutical business of Merck KGaA, (Darmstadt, Germany), announced the appointment of Scott Filosi as Senior Vice President of Managed Markets.//St. Jude Medical (St. Paul, MN) announced Michael T. Rousseau will become President and Chief Executive Officer (CEO) and a member of the St. Jude Medical Board of Directors, effective January 1, 2016. //Rob Perez joined the Board of Directors of Flex Pharma (Boston, MA).//The Board of Directors of Cardinal Health (Dublin, OH) elected Nancy Killefer as an Independent Director.// |
|
|
